We recently compiled a list of the 10 Stocks That Will Make You Rich In 2025. In this article, we are going to take a look at ...

Vertex Pharmaceuticals announced FDA approval for Alyftrek, which expands the company's CF franchise to address around 6,000 ...

OhioHealth Van Wert Hospital's Imaging Department has installed a new state-of-the-art Computed Tomography (CT) Unit to enhance diagnostic capabilities and provide high-level care close to home.

An $8 billion deal Shari Redstone struck with Skydance Media must go through the FCC next year. The new owners are seeking ...

H.C. Wainwright has recently reiterated Vertex Pharmaceuticals Inc (VRTX) stock to Buy rating, as announced on Today, according to Finviz. Earlier, on December 19, 2024, Oppenheimer had reduced the ...

Barclays analyst Gena Wang maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target of $418.00. The company’s shares opened today at $395.72.

Developed in collaboration with Vertex Pharmaceuticals (NASDAQ:VRTX), Casgevy is approved for ... innovating to maintain its competitive edge. The launch of Casgevy is crucial for CRISPR ...

Price Action: VRTX stock is down 13.4% at $387.37 at last check Thursday. UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is a biotechnology company focusing ... a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock ...

Vertex Pharmaceuticals (VRTX) announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor in people with painful lumbosacral ...